Jefferson County v. Express Scripts, Inc.

CourtCourt of Appeals for the Eighth Circuit
DecidedJuly 28, 2025
Docket24-1550
StatusPublished

This text of Jefferson County v. Express Scripts, Inc. (Jefferson County v. Express Scripts, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jefferson County v. Express Scripts, Inc., (8th Cir. 2025).

Opinion

United States Court of Appeals For the Eighth Circuit ___________________________

No. 24-1550 ___________________________

Jefferson County

Plaintiff - Appellee

v.

M.D. Dannie E. Williams; Delmar Primary Care Associates, LLC; Gurpreet S. Padda; Comprehensive Pain Associates, LLC; Interventional Center for Pain Management, P.C., doing business as Padda Institute Center for Interventional Pain Management; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceuticals, Ltd.; Cephalon, Inc.; Watson Laboratories, Inc.; Actavis, LLC; Johnson & Johnson; Janssen Pharmaceuticals, Inc.; Noramco, Inc.; Endo Health Solutions, Inc.; Endo Pharmaceuticals, Inc.; Allergan PLC; Actavis Pharma, Inc.; Mallinckrodt plc; Mallinckrodt LLC; SpecGx, LLC; McKesson Corporation; Cardinal Health, Inc.; Amerisourcebergen Corporation; AmerisourceBergen Drug Corp.; Hunt Fitz Drug, Inc., doing business as Keller Apothecary; Express Scripts Holding Company; Express Scripts Pharmacy, Inc.

Defendants

Express Scripts, Inc.

Defendant - Appellant

Wal-Mart, Inc.; Target Corporation; Walgreen Company; CVS Health Corporation; CVS Pharmacy, Inc.; Caremark Rx, LLC; Caremark PCS Health, LLC; Caremark, LLC; Missouri CVS, LLC; Depomed, Inc.; United Health Group, Inc.; Optum, Inc.

Defendants OptumRx, Inc.

Mylan Pharmaceuticals, Inc.; Mylan N.V.; Richard S. Sackler, M.D.

Defendants ____________

Appeal from United States District Court for the Eastern District of Missouri - St. Louis ____________

Submitted: April 16, 2025 Filed: July 28, 2025 ____________

Before SMITH, SHEPHERD, and KOBES, Circuit Judges. ____________

SMITH, Circuit Judge.

Express Scripts and OptumRX appeal the district court’s 1 order remanding the case to state court based on their untimely removal. We affirm.

I. Background Express Scripts and OptumRX, pharmacy benefit managers (collectively, “PBMs”), administer drug plans for clients, including federal agencies such as the Department of Defense (DoD) and the Veterans Health Administration. Jefferson County, Missouri (County) brought this suit seeking relief under Missouri public nuisance law alleging that the PBMs harmed the public by facilitating prescription opioid abuse. Specifically, they alleged that the PBMs’ preference to distribute these opioids led to 324 deaths and 1,941 emergency room visits, among other alleged

1 The Honorable Matthew T. Schelp, United States District Judge for the Eastern District of Missouri. -2- costs to law enforcement, prosecution, prisons, and addiction treatment. Allegedly, the PBMs do this through formularies and pricing strategies, which “control[] which pain medications reach the marketplace.” R. Doc. 13.

The County filed its initial Petition in the Twenty-Second Judicial Circuit Court of Missouri in the City of St. Louis. It then filed several amended petitions, including a second amended petition on June 15, 2020. On December 1, 2023, the PBMs filed a notice of removal seeking removal pursuant to 28 U.S.C. §§ 1442(a), the federal officer removal statute, and 1446(b)(3). The County then sought remand to state court, which the district court here granted. The PBMs appeal the grant of the remand motion.

This case, at one point, was part of the federal Opioid Multidistrict Litigation (MDL). It had been removed by then-defendant CVS to In re National Prescription Opiate Litigation, 1:17-md-2804-DAP, R. Doc. 1987 (N.D. Ohio July 22, 2019). But on July 24, 2019, the district court in that case severed and remanded this case to a Missouri state court. The PBMs had objected to the severance and remand while the MDL had the case. See id. at R. Doc. No. 1931.

After severance and during discovery, the PBMs requested the County to identify whether the claims that it alleged were related to the PBMs’ contractual services with federal health plans. In response, the County provided a “Red Flag Analysis.” The Red Flag Analysis identified the prescription claims that the County was relying on in its case. The County continually updated this Red Flag Analysis, including the Sixth Red Flag Analysis served on February 3, 2022. The Sixth Red Flag Analysis contained claims made by Express Scripts related to the DoD. On the same day, the County sent an email and letter to the PBMs claiming that it was withdrawing the analysis based on an error. On February 14, 2022, the County sent a new Red Flag Analysis, which still contained federal claims.

On March 10, 2022, the PBMs sent a letter to the County saying that they intended to remove the action to federal court unless the County -3- inform[ed] the PBM Defendants in writing on or before March 14, 2022, that it is withdrawing all challenges to federal prescription claims and [would] not seek recovery from the PBM Defendants based on the federal prescription claims—including but not limited to claims under the Federal Employee Health Benefit Act and claims adjudicated or processed for a plan controlled or sponsored by a federal governmental department or entity (for example, the Department of Defense). . . .

R. Doc. 38-1, at 4. In the letter, the PBMs contended that the County’s “February 14 Red Flag Analysis shows for the first time that the County contends that many different federal prescription claims support its claims against the PBM Defendants. Given that fact, the PBM Defendants are entitled to remove this case to federal court.” Id.

Despite the inclusion of federal prescription claims in the Red Flag Analysis, the County disclaimed any future reliance on these claims. In a March 11, 2022 letter and a March 16, 2022 joint stipulation, the County agreed that it would “not now or at any time in the future seek to establish liability against” the PBMs related to any “Federal Plan.” R. Doc. 1, at 10.

Then, on November 15, 2023, the County produced three expert reports discussing theories of liability. These reports did not differentiate between federal and non-federal prescription claims. The PBMs interpreted the County’s filings as indicating its intent to establish liability using the federal claims. In response, the PBMs moved for removal of the action to federal court under 28 U.S.C. § 1442(a)(1), the federal officer removal statute. The County, in turn, moved the district court to remand the case to state court. The district court granted the County’s motion to remand to state court.

The district court based its remand decision on two considerations. First, citing 28 U.S.C. § 1446(c)(3), the district court found that the PBMs’ removal was untimely. The PBMs were required to file a notice of removal within 30 days of

-4- February 14, 2022, but failed to do so. The district court relied on the PBMs’ acknowledgements in their stipulation with the County and the March 11, 2022 letter sent to the County to establish the PBMs’ awareness of the deadline for seeking removal. See R. Doc. 2-16, at 1 (“[O]n February 14, 2022, [the] County served the PBM [d]efendants with [discovery]. . . . that . . . include[ed] federal prescription claims adjudicated or processed by the PBM [d]efendants. . . .”); see also R. Doc. 38-1, at 4 (“The February 14 Red Flag Analysis shows for the first time that the County contends that many different federal prescription claims support its claims against the PBM [d]efendants. Given that fact, the PBM [d]efendants are entitled to remove this case to federal court.”). The district court determined that the documents established that the PBMs could have sought removal as of February 14, 2022.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Jefferson County v. Express Scripts, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/jefferson-county-v-express-scripts-inc-ca8-2025.